Can't Get Repatha? Here Are Your Options

If you've been prescribed Repatha (evolocumab) but can't fill your prescription — whether due to insurance denials, specialty pharmacy delays, or cost — you're facing a real clinical problem. High LDL cholesterol doesn't pause while you sort out access issues. The good news is that several effective alternatives exist, and your doctor can help you find the right one.

Pro tip: Before switching medications, try Medfinder to locate a pharmacy that has Repatha in stock. Access issues are often resolvable without changing your treatment plan.

What Is Repatha?

Repatha (evolocumab) is a PCSK9 inhibitor — a class of injectable biologic medications that lower LDL cholesterol by helping your liver remove more "bad" cholesterol from your bloodstream. It's manufactured by Amgen and is FDA-approved for:

• Adults with primary hyperlipidemia (including heterozygous familial hypercholesterolemia) who need additional LDL lowering beyond statins
• Patients 10 years and older with homozygous familial hypercholesterolemia (HoFH)
• Adults with established cardiovascular disease to reduce the risk of heart attack, stroke, and coronary revascularization

In clinical trials, Repatha lowered LDL cholesterol by an average of 55-75% when added to statin therapy — a dramatic reduction that few other medications can match.

How Does Repatha Work?

Your liver has LDL receptors on its surface that pull LDL cholesterol out of your blood. A protein called PCSK9 breaks down these receptors, reducing your liver's ability to clear cholesterol. Repatha is a monoclonal antibody that binds to PCSK9 and blocks it from destroying LDL receptors. The result: more receptors stay active, more LDL gets cleared, and your cholesterol drops significantly.

This mechanism is fundamentally different from statins (which reduce cholesterol production) and ezetimibe (which blocks cholesterol absorption in the gut), which is why Repatha can be so effective when other medications aren't enough.

Alternative Medications to Repatha

Always consult with your healthcare provider before making any changes to your medication regimen. The right alternative depends on why you need Repatha, how much LDL lowering you need, and what other medications you're already taking.

1. Praluent (Alirocumab)

Praluent is the most direct alternative to Repatha. It's another PCSK9 inhibitor monoclonal antibody with a very similar mechanism of action and comparable LDL-lowering efficacy (50-60% reduction).

• How it's given: Subcutaneous injection every 2 weeks (75 mg or 150 mg) or 300 mg once monthly
• Key difference from Repatha: Different dosing options; some patients find one autoinjector easier to use than the other
• Why consider it: If Repatha is unavailable or your insurance covers Praluent preferentially. Some plans have one PCSK9 inhibitor on formulary but not the other
• Manufacturer: Regeneron/Sanofi

2. Leqvio (Inclisiran)

Leqvio represents a newer approach to targeting PCSK9. Instead of blocking the PCSK9 protein like Repatha does, Leqvio uses small interfering RNA (siRNA) technology to reduce PCSK9 production at the genetic level.

• How it's given: Subcutaneous injection administered by a healthcare provider — not at home. Initial dose, then at 3 months, then every 6 months
• Key difference from Repatha: Only 2 injections per year (after loading doses) vs. 12-26 per year with Repatha. Given in-office, eliminating home injection and pharmacy stocking concerns
• Why consider it: Excellent option if you struggle with self-injection adherence or have persistent pharmacy access issues. The in-office administration bypasses specialty pharmacy bottlenecks entirely
• LDL reduction: Approximately 50% on top of statin therapy
• Manufacturer: Novartis

3. Nexletol (Bempedoic Acid)

Nexletol is an oral medication — a pill, not an injection — that lowers LDL cholesterol through a mechanism related to but different from statins. It inhibits ATP citrate lyase (ACL), an enzyme upstream of the target that statins block.

• How it's taken: One 180 mg tablet daily by mouth
• Key difference from Repatha: Oral pill vs. injection; less potent LDL lowering (15-25% reduction) but much simpler to access and take
• Why consider it: Available at regular retail pharmacies, no cold storage needed, generally less expensive. Good option for statin-intolerant patients. Also available combined with ezetimibe as Nexlizet
• Manufacturer: Esperion

4. Zetia (Ezetimibe)

Ezetimibe is a cholesterol absorption inhibitor that blocks the absorption of cholesterol in the small intestine. It's been available as a generic for years and is one of the most affordable cholesterol medications.

• How it's taken: One 10 mg tablet daily by mouth
• Key difference from Repatha: Much less potent (15-20% LDL reduction vs. 55-75%), but widely available, very affordable ($10-30/month generic), and no injection required
• Why consider it: If you haven't tried ezetimibe yet, most insurers require a trial before approving a PCSK9 inhibitor. Adding ezetimibe to your statin may provide enough additional LDL lowering to reach your goal

Final Thoughts

While Repatha is one of the most powerful cholesterol-lowering medications available, access barriers are real. Before switching to an alternative, take these steps:

1. Use Medfinder to check if Repatha is available at another pharmacy
2. Confirm your prior authorization status and appeal any denials
3. Look into the Amgen copay card and patient assistance programs

If you do need to switch, Praluent offers the closest match in terms of efficacy, Leqvio eliminates the home injection and pharmacy stocking hassle entirely, and Nexletol or ezetimibe provide oral options available at any pharmacy.

Talk to your cardiologist or prescriber about which alternative makes the most sense for your specific situation. For more on locating Repatha, read our guide on how to find Repatha in stock near you.